KMID : 0939920160480041443
|
|
´ëÇѾÏÇÐȸÁö 2016 Volume.48 No. 4 p.1443 ~ p.1447
|
|
Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide
|
|
Choi Ae-Ry
Kang Young-Kyung Lim Se-Won Kim Dong-Ho Lim Jung-Sub Lee Jun-Ah
|
|
Abstract
|
|
|
Hepatic sinusoidal obstruction syndrome (SOS) is a life-threatening syndrome that generally occurs as a complication after hematopoietic stem cell transplantation or, less commonly, after conventional chemotherapy. Regarding SOS in rhabdomyosarcoma patients who received conventional chemotherapy, the doses of chemotherapeutic agents are associated with the development of SOS. Several cases of SOS in rhabdomyosarcoma patients after receiving chemotherapy with escalated doses of cyclophosphamide have been reported. Here, we report on a 9-year-old female with rhabdomyosarcoma who developed severe SOS after receiving chemotherapy consisting of vincristine, actinomycin-D, and a moderate dose of cyclophosphamide. She was treated successfully with defibrotide without sequelae to the liver.
|
|
KEYWORD
|
|
Hepatic veno-occlusive disease, Rhabdomyosarcoma, Defibrotide
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|